These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 37334160)

  • 1. COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery.
    Kumar S; Basu M; Ghosh P; Pal U; Ghosh MK
    Genes Dis; 2023 Jul; 10(4):1402-1428. PubMed ID: 37334160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting potential druggable targets against SARS-CoV-2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review.
    Sohag AAM; Hannan MA; Rahman S; Hossain M; Hasan M; Khan MK; Khatun A; Dash R; Uddin MJ
    Drug Dev Res; 2020 Dec; 81(8):919-941. PubMed ID: 32632960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State-of-the-art Tools to Elucidate the Therapeutic Potential of TAT-peptide (TP) Conjugated Repurposing Drug Against SARS-CoV-2 Spike Glycoproteins.
    Ansari MA; Alomary MN; Jamal QMS; Almoshari Y; Salawi A; Almahmoud SA; Khan J
    Curr Pharm Des; 2022; 28(46):3706-3719. PubMed ID: 36278465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment.
    Taibe NS; Kord MA; Badawy MA; Shytaj IL; Elhefnawi MM
    Ther Adv Respir Dis; 2022; 16():17534666221132736. PubMed ID: 36282077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19: Potential Repurposing Drugs.
    Leowattana W
    Infect Disord Drug Targets; 2022; 22(1):e110122191924. PubMed ID: 33645490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19: Clinical status of vaccine development to date.
    Kumar S; Basu M; Ghosh P; Ansari A; Ghosh MK
    Br J Clin Pharmacol; 2023 Jan; 89(1):114-149. PubMed ID: 36184710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TAT-peptide conjugated repurposing drug against SARS-CoV-2 main protease (3CLpro): Potential therapeutic intervention to combat COVID-19.
    Ansari MA; Jamal QMS; Rehman S; Almatroudi A; Alzohairy MA; Alomary MN; Tripathi T; Alharbi AH; Adil SF; Khan M; Shaheer Malik M
    Arab J Chem; 2020 Nov; 13(11):8069-8079. PubMed ID: 34909057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2.
    Niranjan V; Setlur AS; Karunakaran C; Uttarkar A; Kumar KM; Skariyachan S
    Struct Chem; 2022; 33(5):1585-1608. PubMed ID: 35938064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?
    Indari O; Jakhmola S; Manivannan E; Jha HC
    Front Pharmacol; 2021; 12():632677. PubMed ID: 33762954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates.
    Rodrigues L; Bento Cunha R; Vassilevskaia T; Viveiros M; Cunha C
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2.
    Tammam SN; El Safy S; Ramadan S; Arjune S; Krakor E; Mathur S
    J Control Release; 2021 Sep; 337():258-284. PubMed ID: 34293319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Discovery Strategies for SARS-CoV-2.
    Shyr ZA; Gorshkov K; Chen CZ; Zheng W
    J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in the repurposing of drugs/molecules for the management of COVID-19.
    Sharma D; Kunamneni A
    Expert Rev Anti Infect Ther; 2021 Jul; 19(7):889-897. PubMed ID: 33270490
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug Discovery by Drug Repurposing: Combating COVID-19 in the 21st Century.
    Sanghai N; Shafiq K; Tranmer GK
    Mini Rev Med Chem; 2021; 21(1):3-9. PubMed ID: 32838716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing anticancer drugs for the management of COVID-19.
    El Bairi K; Trapani D; Petrillo A; Le Page C; Zbakh H; Daniele B; Belbaraka R; Curigliano G; Afqir S
    Eur J Cancer; 2020 Dec; 141():40-61. PubMed ID: 33125946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of repurposed antiviral drugs: Lessons from COVID-19.
    Martinez MA
    Drug Discov Today; 2022 Jul; 27(7):1954-1960. PubMed ID: 35192924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational identification of repurposed drugs against viruses causing epidemics and pandemics via drug-target network analysis.
    Rajput A; Thakur A; Rastogi A; Choudhury S; Kumar M
    Comput Biol Med; 2021 Sep; 136():104677. PubMed ID: 34332351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.
    Kumar P; Sah AK; Tripathi G; Kashyap A; Tripathi A; Rao R; Mishra PC; Mallick K; Husain A; Kashyap MK
    Mol Cell Biochem; 2021 Feb; 476(2):553-574. PubMed ID: 33029696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
    Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM
    Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.